October 10, 2023
Explore Our Latest News
Stay Up to Date on the Breakthroughs and Events Shaping the Future of Radiopharmaceuticals
Upcoming Events
July 21 – 23, 2026 | La Jolla, CA
Targeted Radiopharmaceuticals Summit USA
October 17 – 21, 2026 | Vienna, Austria
EANM Annual Meeting
Press Releases
July 11, 2023
Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging
ReadJune 21, 2023
UPMC and PharmaLogic Partner to Develop Novel Radiopharmaceuticals at New Facility in Pittsburgh
ReadJune 13, 2023
PharmaLogic and Evergreen Theragnostics Announce Partnership for Sales and Distribution of OCTEVY™ (Kit for Preparation of Ga 68 DOTATOC Injection), pending FDA approval in 2H 2023
ReadMay 15, 2023
NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours
ReadMay 15, 2023